Načítá se...
Identifying genetic modulators of statin response using subject-derived lymphoblastoid cell lines
Although statins (3-hydroxy-3-methylglutaryl-CoA reductase inhibitors) have proven effective in reducing plasma low-density lipoprotein levels and risk of cardiovascular disease, their lipid lowering efficacy is highly variable among individuals. Furthermore, statin treatment carries a small but sig...
Uloženo v:
| Vydáno v: | Pharmacogenomics |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8115385/ https://ncbi.nlm.nih.gov/pubmed/33858191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0197 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|